Curative Embolization of Arteriovenous Malformations.
AVMs
Arteriovenous malformations
Curative
Embolization
Spetzler-Martin
Transarterial
Transvenous
Journal
World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
22
06
2018
revised:
15
01
2019
accepted:
17
01
2019
pubmed:
9
2
2019
medline:
21
1
2020
entrez:
9
2
2019
Statut:
ppublish
Résumé
Arteriovenous malformations have a significant cumulative risk for hemorrhage. Treatment options include observation, microsurgical resection, stereotactic radiosurgery, embolization, and multimodal treatment. Treatment selection and timing are based on arteriovenous malformation (AVM) features including size, location in eloquent versus noneloquent parenchyma, pattern of venous drainage, surgical access, rupture status, and previous treatments. Spetzler-Martin grading is the most commonly used classification system used to select treatment, with grades I and II lesions amenable to surgical resection alone, grade III lesions typically treated via a multimodal approach entailing preoperative embolization followed by microsurgical resection, and grades IV and V lesions generally observed unless ruptured. Embolization in the treatment of AVMs is thus most commonly used as a preoperative or, occasionally, preradiosurgical adjunct. The concept of curative AVM embolization is an attractive one that has emerged within the past few decades, with increasing clinical evidence for its safety and efficacy in recent years. Obliteration rates for curative AVM embolization will be improved by innovation in endovascular techniques and technologies.
Identifiants
pubmed: 30735875
pii: S1878-8750(19)30266-9
doi: 10.1016/j.wneu.2019.01.166
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
467-486Informations de copyright
Copyright © 2019. Published by Elsevier Inc.